» Articles » PMID: 33618612

Silencing of LINC00284 Inhibits Cell Proliferation and Migration in Oral Squamous Cell Carcinoma by the MiR-211-3p/MAFG Axis and FUS/KAZN Axis

Overview
Specialties Oncology
Pharmacology
Date 2021 Feb 23
PMID 33618612
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Oral squamous cell carcinoma (OSCC) is one of the most common malignancies worldwide. Emerging evidence has suggested that long noncoding RNAs (lncRNAs) play vital roles in various biological processes of cancers, such as cell proliferation, migration, invasion, and apoptosis. As reported previously, long intergenic non-protein coding RNA 284 (LINC00284) is an important regulator in multiple cancers. However, the biological role, as well as regulatory mechanism of LINC00284 in OSCC, has not been investigated. In our study, RT-qPCR results indicated that LINC00284 was significantly upregulated in OSCC tissues and cells. Moreover, loss-of-function experiments demonstrated that LINC00284 downregulation suppressed cell proliferation and migration and facilitated cell apoptosis. Mechanistically, we found that LINC00284 sponged microRNA 211-3p (miR-211-3p) to upregulate MAF bZIP transcription factor G (MAFG) expression in OSCC cells. Additionally, LINC00284 interacted with FUS protein to increase KAZN mRNA stability. Functional assays showed that either MAFG or KAZN overexpression promoted the malignant behaviors of OSCC cells. Through a series of rescue assays, we found that the inhibitory effect of silencing LINC00284 on OSCC cells can be reversed by upregulated MAFG and KAZN. Overall, silencing LINC00284 inhibits the malignant characteristics of OSCC cells by downregulating MAFG and inhibiting the binding of FUS to KAZN mRNA.

Citing Articles

Novel insights on oral squamous cell carcinoma management using long non-coding RNAs.

Sur S, Davray D, Basu S, Kheur S, Pal J, Nagar S Oncol Res. 2024; 32(10):1589-1612.

PMID: 39308526 PMC: 11413828. DOI: 10.32604/or.2024.052120.


ALDH1A3 promotes invasion and metastasis in triple-negative breast cancer by regulating the plasminogen activation pathway.

Bharadwaj A, McLean M, Dahn M, Cahill H, Wasson M, Arun R Mol Oncol. 2023; 18(1):91-112.

PMID: 37753740 PMC: 10766202. DOI: 10.1002/1878-0261.13528.


Non-Coding RNAs in Oral Cancer: Emerging Roles and Clinical Applications.

Dey S, Biswas B, Manoj Appadan A, Shah J, Pal J, Basu S Cancers (Basel). 2023; 15(15).

PMID: 37568568 PMC: 10417002. DOI: 10.3390/cancers15153752.


COX10-AS1-mediated miR-361-5p regulated cell invasion and migration by targeting SPRY1 in oral squamous cell carcinoma.

Deng J, Wu M Am J Transl Res. 2023; 15(3):2191-2206.

PMID: 37056821 PMC: 10086905.


The role and regulation of Maf proteins in cancer.

Deng Y, Lu L, Zhang H, Fu Y, Liu T, Chen Y Biomark Res. 2023; 11(1):17.

PMID: 36750911 PMC: 9903618. DOI: 10.1186/s40364-023-00457-w.


References
1.
Dykes I, Emanueli C . Transcriptional and Post-transcriptional Gene Regulation by Long Non-coding RNA. Genomics Proteomics Bioinformatics. 2017; 15(3):177-186. PMC: 5487525. DOI: 10.1016/j.gpb.2016.12.005. View

2.
Chang Y, Zhang K, Hu Z, Qi H, Shi Z, Han X . Hypoxia-regulated lncRNAs in cancer. Gene. 2015; 575(1):1-8. DOI: 10.1016/j.gene.2015.08.049. View

3.
Lindemann A, Takahashi H, Patel A, Osman A, Myers J . Targeting the DNA Damage Response in OSCC with TP53 Mutations. J Dent Res. 2018; 97(6):635-644. PMC: 5960880. DOI: 10.1177/0022034518759068. View

4.
Hosni A, McMullen C, Huang S, Xu W, Su J, Bayley A . Lymph node ratio relationship to regional failure and distant metastases in oral cavity cancer. Radiother Oncol. 2017; 124(2):225-231. DOI: 10.1016/j.radonc.2017.06.018. View

5.
Krol J, Loedige I, Filipowicz W . The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet. 2010; 11(9):597-610. DOI: 10.1038/nrg2843. View